My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}

Want to join the conversation?

$BSX {{ '2015-10-28T12:34:50+0000' | timeago}} • Webcast

Adjusted GM for 3Q15 was 72.5% for $BSX, achieving the high end of guidance, up 140 BP YoverY. Adjusted SG&A expenses were $697MM or 36.9% of sales in 3Q15, down 110 BP from last year; expects FY15 adjusted SG&A rate to be approx. 37%.

User Josh Allan {{ '2016-10-27T15:39:01+0000' | timeago}}

Jeff Bezos, my inspiration next to Steve Jobs is going to review the Everything Store $AMZN's financial results today after hours. As an investor/user, I like Amazon Prime and it's success over several parts of the world. What's your take on Amazon?

User RC xNair {{ '2016-10-27T13:31:32+0000' | timeago}}

Of all the Wall St firms out there, Goldman Sachs $GS is the most revered for the way they're run - hiring the best, highly competitive, a closely-knit peer group and making tons of profits for the shareholders. An interesting interview of its CEO Llyod Blankfein by Carlyle groups chief David Rubenstein

User Ramesh Raju {{ '2016-10-27T10:38:07+0000' | timeago}}

Deutsche Bank posts Q3 net profit of 278 million euros.

User Vishnu Beri {{ '2016-10-27T01:52:28+0000' | timeago}}

Great results from $TSLA, however the question remains if Tesla can continue to scale up to produce the cars in the quantity it promises. Model 3 numbers need to be in multiples of what they are producing right now. Wish them the best, will keep an eye as I am still not convinced that they can scale easily.

User Michael Michael {{ '2016-10-26T23:46:35+0000' | timeago}}

Watching $TSLA Oct 28th $215 Calls for possible entry

$TGNA {{ '2016-10-28T14:06:04+0000' | timeago}} • Announcement

$TGNA's BoD declared a quarterly dividend of 14 cents per share. The dividend is payable on Jan. 3, 2017 to stockholders of record on Dec. 9, 2016.

$GT {{ '2016-10-28T14:01:42+0000' | timeago}} • Webcast

$GT expects to continue its progress toward its 2020 target of $3Bil in segment operating income and $3.5-4.0Bil in returns to shareholders as part of its 2017-2020 capital allocation plan.

$BIIB {{ '2016-10-28T14:00:32+0000' | timeago}} • Announcement

$BIIB said its New Drug Application for nusinersen, investigational treatment for spinal muscular atrophy, has been accepted by the U.S. Food and Drug Administration for Priority Review, and that its Marketing Authorization Application has been validated by the European Medicines Agency. $BIIB plans to market nusinersen under brand name Spinraza.

$LEG {{ '2016-10-28T14:00:16+0000' | timeago}} • Webcast

$LEG is experiencing some softness in welded tube business. The company lost a little bit of market share, hurt by the reduction in selling price. The aerospace business was down for two quarters in a row, $LEG said.

$ALLE {{ '2016-10-28T13:55:43+0000' | timeago}} • Webcast

$ALLE said it experienced higher commodity prices in 3Q16. The company expects additional commodity inflation pressure to continue. Investments triggered 60 basis points headwinds in the quarter, and the company expects additional investment headwinds to continue through the remainder of the year.